Marcia Frellick on Muck Rack

Marcia Frellick

Verified
Chicago
As seen in: WebMD, Phys.org, Medscape, Medscape Duestch, Medscape France, Medscape Noticias Médicas, Medscape PT, Science News, Medical Xpress, MedicineNet and
-TCG WORLD-Trader/crypto|BAPC | Thieves List | MEEPS | The Matic Greys | FMFH | Cyber Hornets/Animus | Elongator | 🐲DRC 2 |
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Marcia

Contact Marcia, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Sharp Rise in Retirements, Thoughts of Leaving Medical Practice

|
By Marcia Frellick Verified
| MedCentral
More physicians are questioning whether to stay in practice. Nearly half (44%) of respondents to this year’s MedCentral Evolution of Medical Practice survey said they had considered leaving medical practice since the start of 2026, compared with 35% of respondents in last year’s survey. Physicians point to mounting complex clinical demands, persistent stress, and an aging workforce as reasons they are reconsidering their future in medicine.
Open in Who Shared Issue with article?

Higher Mortality Risk in Patients With IBS Using Antidepressants

|
By Marcia Frellick Verified
| Medscape Verified
Antidepressants and certain antidiarrheal drugs, such as loperamide and diphenoxylate, were linked to a slightly higher risk for death in adults with irritable bowel syndrome (IBS), according to findings of a recent study. The findings, published in Communications Medicine, raise concerns about the safety of antidepressants and mu receptor agonists in IBS treatment and call for new considerations in long-term prescribing, the authors wrote.
Open in Who Shared Issue with article?

Internationale Unterschiede bei Sonnencremes: Warum lässt die FDA jetzt erst einen UV-Filter zu, der in Europa seit Jahrzehnten im Handel ist?

|
By Marcia Frellick Verified, Michael van den Heuvel
| Medscape Duestch Verified
Die US-Arzneimittelbehörde FDA hat mit Bemotrizinol erstmals seit 1999 einen neuen UV-Filter für Sonnenschutzmittel zugelassen. Während Verbraucher in Europa seit mehr als 2 Jahrzehnten von modernen Breitbandfiltern profitieren, waren Amerikaner bislang auf eine deutlich ältere Generation von UV-Filtern angewiesen. Die Entscheidung könnte den Beginn einer neuen Ära des Sonnenschutzes in den USA markieren [1].
Open in Who Shared Issue with article?
See all 1,829 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified